Skip to Content

3230 WPI (Meloxicam 7.5 mg)

Pill with imprint 3230 WPI is Yellow, Round and has been identified as Meloxicam 7.5 mg. It is supplied by Watson Pharmaceuticals.

Meloxicam is used in the treatment of osteoarthritis; rheumatoid arthritis; juvenile rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 3230 WPI

Meloxicam 7.5 mg 3230 WPI

Meloxicam

Imprint
3230 WPI
Strength
7.5 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-3230

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.